 Alan Elder
Concepts (70)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Semaphorins | 4 | 2025 | 32 | 1.900 |
Why?
| | Antigens, CD | 5 | 2025 | 521 | 1.610 |
Why?
| | Mammary Glands, Animal | 3 | 2025 | 129 | 1.190 |
Why?
| | Breast Neoplasms | 6 | 2025 | 2234 | 1.110 |
Why?
| | Prions | 2 | 2015 | 46 | 0.880 |
Why?
| | B7-H1 Antigen | 2 | 2025 | 217 | 0.840 |
Why?
| | Lymphatic Vessels | 3 | 2020 | 64 | 0.810 |
Why?
| | Immune Tolerance | 1 | 2025 | 362 | 0.790 |
Why?
| | Macrophages | 2 | 2020 | 1544 | 0.720 |
Why?
| | Postpartum Period | 3 | 2020 | 337 | 0.690 |
Why?
| | Breast | 1 | 2020 | 149 | 0.630 |
Why?
| | Mammary Glands, Human | 1 | 2018 | 64 | 0.570 |
Why?
| | Extracellular Matrix | 1 | 2020 | 528 | 0.500 |
Why?
| | Epithelial Cells | 2 | 2021 | 1094 | 0.490 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2020 | 1396 | 0.430 |
Why?
| | Prion Diseases | 1 | 2013 | 15 | 0.430 |
Why?
| | Tumor Microenvironment | 3 | 2025 | 672 | 0.310 |
Why?
| | Neoplasm Metastasis | 3 | 2025 | 657 | 0.310 |
Why?
| | GPI-Linked Proteins | 3 | 2025 | 72 | 0.250 |
Why?
| | Cell Plasticity | 1 | 2025 | 35 | 0.230 |
Why?
| | Mesocricetus | 2 | 2015 | 39 | 0.230 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2025 | 165 | 0.220 |
Why?
| | Cell Line, Tumor | 4 | 2025 | 3405 | 0.220 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 2 | 2019 | 61 | 0.190 |
Why?
| | Anoikis | 1 | 2021 | 31 | 0.180 |
Why?
| | Animals | 7 | 2025 | 36847 | 0.160 |
Why?
| | Mice | 5 | 2025 | 17757 | 0.160 |
Why?
| | Membrane Glycoproteins | 2 | 2019 | 500 | 0.150 |
Why?
| | Mice, Inbred BALB C | 2 | 2019 | 1269 | 0.150 |
Why?
| | Lactation | 1 | 2020 | 181 | 0.150 |
Why?
| | Lymphangiogenesis | 1 | 2018 | 27 | 0.150 |
Why?
| | Crosses, Genetic | 1 | 2018 | 137 | 0.150 |
Why?
| | Integrins | 1 | 2018 | 95 | 0.140 |
Why?
| | Antibodies, Monoclonal | 1 | 2025 | 1430 | 0.140 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 250 | 0.130 |
Why?
| | Mice, Knockout | 2 | 2025 | 3008 | 0.130 |
Why?
| | Deer | 1 | 2015 | 32 | 0.120 |
Why?
| | Administration, Intranasal | 1 | 2015 | 89 | 0.120 |
Why?
| | Injections, Intravenous | 1 | 2015 | 207 | 0.120 |
Why?
| | Blood Chemical Analysis | 1 | 2015 | 99 | 0.110 |
Why?
| | Aging | 1 | 2025 | 1864 | 0.110 |
Why?
| | Mice, Inbred C57BL | 3 | 2021 | 5749 | 0.110 |
Why?
| | Phosphotungstic Acid | 1 | 2013 | 3 | 0.110 |
Why?
| | Cell Movement | 1 | 2018 | 968 | 0.110 |
Why?
| | Cricetinae | 1 | 2013 | 289 | 0.100 |
Why?
| | Female | 6 | 2025 | 72796 | 0.100 |
Why?
| | Endothelial Cells | 1 | 2018 | 778 | 0.100 |
Why?
| | Administration, Oral | 1 | 2015 | 813 | 0.100 |
Why?
| | Humans | 7 | 2025 | 136768 | 0.080 |
Why?
| | Immunohistochemistry | 1 | 2013 | 1733 | 0.080 |
Why?
| | Time Factors | 1 | 2015 | 6808 | 0.060 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2025 | 209 | 0.050 |
Why?
| | Integrin alpha6 | 1 | 2021 | 9 | 0.050 |
Why?
| | Caspase 7 | 1 | 2021 | 22 | 0.050 |
Why?
| | Integrin beta1 | 1 | 2021 | 25 | 0.050 |
Why?
| | Caspase 3 | 1 | 2021 | 246 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2021 | 685 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2021 | 810 | 0.040 |
Why?
| | Adipocytes | 1 | 2021 | 222 | 0.040 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2021 | 327 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2021 | 437 | 0.040 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2019 | 68 | 0.040 |
Why?
| | Cell Survival | 1 | 2021 | 1116 | 0.040 |
Why?
| | Phosphorylation | 1 | 2021 | 1758 | 0.030 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2021 | 800 | 0.030 |
Why?
| | Phenotype | 1 | 2021 | 3189 | 0.020 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 913 | 0.020 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2019 | 1095 | 0.020 |
Why?
| | Male | 1 | 2015 | 67311 | 0.020 |
Why?
| | Adult | 1 | 2025 | 37630 | 0.010 |
Why?
|
|
Elder's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|